Although originally identified due to their potent activity against microbial pathogens, several CAPs also exhibit cytolytic activity against a range of mammalian tumor cells (Lichtenstein et al., 1986; Cruciani et al., 1991; Hancock and Sahl, 2006; Schweizer, 2009). Here, CAPS is linked to neoplasm.